Precancerous cervical lesions and associated factors among women on antiretroviral therapy at Dukem Health Center, Central Ethiopia: A cross-sectional study

被引:1
作者
Lemma, Tamiru Mamo [1 ]
Bala, Elias Teferi [2 ]
Hordofa, Mulatu Ayana [2 ]
Solbana, Lencho Kajela [3 ,4 ]
机构
[1] Dukem Hlth Ctr, Oromia Hlth Bur, Addis Ababa, Ethiopia
[2] Ambo Univ, Dept Publ Hlth, Ambo, Ethiopia
[3] Assosa Univ, Coll Hlth Sci, Dept Nursing, Assosa, Ethiopia
[4] Assosa Univ, Coll Hlth Sci, Assosa, Ethiopia
关键词
cervical cancer; Ethiopia; HIV-positive women; precancerous cervical lesions; HIV-INFECTED WOMEN; CANCER; RISK; PREVALENCE;
D O I
10.1002/hsr2.1972
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background and Aims: Cervical cancer is a global public health problem and the second most common cancer which leads to morbidity and mortality among women in developing countries like Ethiopia. In Ethiopia, annually 6294 new cervical cancer cases and 4884 deaths are estimated in 2018 alone. This study aimed to assess the prevalence and associated factors of precancerous cervical lesions among women on antiretroviral therapy (ART) at Dukem Health Center, Central Ethiopia. Methods: An institution-based cross-sectional study was carried out among randomly selected 257 women receiving ART at Dukem Health Center. Data were collected using a pretested structured questionnaire, medical record review, and visual inspection with acetic acid. Collected data were entered into Epi-info 7.4 and exported to SPSS version 26 for analysis. The prevalence of precancerous cervical lesions and the characteristics of study participants were identified. Utilizing both binary and multivariable logistic regression models, the existence and degree of association with precancerous cervical lesions were determined with a p value < 0.05 and a 95% confidence interval. Results: The prevalence of precancerous cervical lesions was 16% (95% CI: 11.7-20.6). Significant association was found between precancerous cervical lesions and a history of STIs (AOR = 4.30, 95% CI: 1.48-12.49), oral contraceptive use (AOR = 6.56, 95% CI: 2.10-20.50), having multiple lifetime sexual partners (AOR = 2.53: 95% CI: 1.05-6.10), and a recent CD4 count of less than 200 cells/mm(3) (AOR: 11.33, 95% CI: 2.88-24.58). Conclusion: In the study area, the prevalence of precancerous cervical lesions was relatively high. Therefore, concerned bodies are recommended to increase awareness of the prevention of sexually transmitted diseases and limit sexual partners.
引用
收藏
页数:7
相关论文
共 35 条
[1]   Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective Study [J].
Abraham, Alison G. ;
D'Souza, Gypsyamber ;
Jing, Yuezhou ;
Gange, Stephen J. ;
Sterling, Timothy R. ;
Silverberg, Michael J. ;
Saag, Michael S. ;
Rourke, Sean B. ;
Rachlis, Anita ;
Napravnik, Sonia ;
Moore, Richard D. ;
Klein, Marina B. ;
Kitahata, Mari M. ;
Kirk, Gregory D. ;
Hogg, Robert S. ;
Hessol, Nancy A. ;
Goedert, James J. ;
Gill, M. John ;
Gebo, Kelly A. ;
Eron, Joseph J. ;
Engels, Eric A. ;
Dubrow, Robert ;
Crane, Heidi M. ;
Brooks, John T. ;
Bosch, Ronald J. ;
Strickler, Howard D. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 (04) :405-413
[2]  
[Anonymous], 2006, International Health Conference, P1
[3]   The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study [J].
Bateman, Allen C. ;
Katundu, Katundu ;
Mwanahamuntu, Mulindi H. ;
Kapambwe, Sharon ;
Sahasrabuddhe, Vikrant V. ;
Hicks, Michael L. ;
Chi, Benjamin H. ;
Stringer, Jeffrey S. A. ;
Parham, Groesbeck P. ;
Chibwesha, Carla J. .
BMC CANCER, 2015, 15
[4]  
Belayneh T, 2019, INT J HEALTH SCI-IJH, V13, P4
[5]  
Belete Netsanet, 2015, Gynecol Oncol Res Pract, V2, P6, DOI [10.1186/s40661-015-0012-3, 10.1186/s40661-015-0012-3]
[6]   Risk factors for precancerous cervical lesion among women screened for cervical cancer in south Ethiopia: Unmatched case-control study [J].
Beyene, Tesfalidet ;
Akibu, Mohammed ;
Bekele, Henok ;
Seyoum, Wengelawit .
PLOS ONE, 2021, 16 (07)
[7]   Vaccination to prevent human papillomavirus infections: From promise to practice [J].
Bloem, Paul ;
Ogbuanu, Ikechukwu .
PLOS MEDICINE, 2017, 14 (06)
[8]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[9]  
Deksissa Zewdie Mulissa, 2015, BMC Res Notes, V8, P618, DOI [10.1186/s13104-015-1594-x, 10.1186/s13104-015-1594-x]
[10]   Incidence and progression of cervical lesions in women with HIV: a systematic global review [J].
Denslow, Sheri A. ;
Rositch, Anne F. ;
Firnhaber, Cynthia ;
Ting, Jie ;
Smith, Jennifer S. .
INTERNATIONAL JOURNAL OF STD & AIDS, 2014, 25 (03) :163-177